Fei Xu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Fei Xu has a total of 241 co-authors. Here are the top co-authors by number of shared publications:
- Xi Lin
Human Institute, ShanghaiTech University, Shanghai, China
10 shared publications - Suwen Zhao
ShanghaiTech University
7 shared publications Yang Yue
Human Institute, ShanghaiTech University, Shanghai, China
7 shared publicationsBo Chen
Human Institute School of Life Science and Technology Shanghai Key Laboratory of High‐resolution Electron Microscopy ShanghaiTech University Shanghai China
5 shared publicationsJunlin Liu
Human Institute, ShanghaiTech University, Shanghai, China
5 shared publications- Lijie Wu
Human Institute, ShanghaiTech University, Shanghai, China
5 shared publications
Latest Publications
- 17 August 2026
- Published by Springer Nature in Acta Pharmacologica Sinica
- p. 1-9
Direct β-arrestin engagement by the non-canonical WNT receptor FZD6 via a shallow binding pocket
- 17 August 2026
- Published by Springer Nature in Acta Pharmacologica Sinica
- p. 1-9
Direct β-arrestin engagement by the non-canonical WNT receptor FZD6 via a shallow binding pocket
- Open Access
- 5 November 2025
- Published by Oxford University Press (OUP) in Protein & Cell
- Vol. 17 (4) , 372-377
Molecular recognition at the opioid-modulating neuropeptide FF receptor 1
- 5 November 2025
- Published by Oxford University Press (OUP) in Protein & Cell
- Vol. 17 (4) , 372-377
Open AccessMolecular recognition at the opioid-modulating neuropeptide FF receptor 1
- Open Access
- 27 September 2025
- Published by Springer Nature in Cell Discovery
- Vol. 11 (1) , 1-4
Chemosensation of the pheromone spermine by the olfactory TAAR-like receptor TAAR348
- 27 September 2025
- Published by Springer Nature in Cell Discovery
- Vol. 11 (1) , 1-4
Open AccessChemosensation of the pheromone spermine by the olfactory TAAR-like receptor TAAR348
- 15 August 2025
- Published by Springer Nature in Cell Research
- Vol. 35 (11) , 913-916
Constitutive arrestin recruitment by orphan GPR52 via an atypical binding mode
- 15 August 2025
- Published by Springer Nature in Cell Research
- Vol. 35 (11) , 913-916
Constitutive arrestin recruitment by orphan GPR52 via an atypical binding mode
- Open Access
- 11 August 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1)
Mechanistic insights into the versatile stoichiometry and biased signaling of the apelin receptor-arrestin complex
The apelin receptor (APJR) plays a pivotal role in regulating cardiovascular and metabolic health1,2. Understanding the mechanisms of biased agonism at APJR is crucial for drug discovery, as stimulation of the β-arrestin pathway may lead to some adverse effects3. Structural analyses of APJR-Gi complexes have clarified the structural basis of receptor dimerization and activation4,5, yet the absence of structural data on APJR-arrestin complexes has impeded a comprehensive understanding of APJR stoichiometry in the dual signaling pathways and biased agonism. Here, we present APJR-β-arrestin1 structures bound to a clinical drug analog, revealing 2:2 and 2:1 stoichiometries associated with differential β-arrestin recruitment. Through comparison of the two transducer-coupled APJR structures bound to the same ligand, we identify key residues and motifs crucial for directing biased signaling. These findings highlight APJR’s versatile stoichiometry in coupling with β-arrestin and Gi proteins, establishing a framework for understanding biased agonism and guiding the development of therapeutics.
- 11 August 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1)
Open AccessMechanistic insights into the versatile stoichiometry and biased signaling of the apelin receptor-arrestin complex
The apelin receptor (APJR) plays a pivotal role in regulating cardiovascular and metabolic health1,2. Understanding the mechanisms of biased agonism at APJR is crucial for drug discovery, as stimulation of the β-arrestin pathway may lead to some adverse effects3. Structural analyses of APJR-Gi complexes have clarified the structural basis of receptor dimerization and activation4,5, yet the absence of structural data on APJR-arrestin complexes has impeded a comprehensive understanding of APJR stoichiometry in the dual signaling pathways and biased agonism. Here, we present APJR-β-arrestin1 structures bound to a clinical drug analog, revealing 2:2 and 2:1 stoichiometries associated with differential β-arrestin recruitment. Through comparison of the two transducer-coupled APJR structures bound to the same ligand, we identify key residues and motifs crucial for directing biased signaling. These findings highlight APJR’s versatile stoichiometry in coupling with β-arrestin and Gi proteins, establishing a framework for understanding biased agonism and guiding the development of therapeutics.
- Open Access
- 2 January 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-12
Structural insights into the regulation of monomeric and dimeric apelin receptor
The apelin receptor (APJR) emerges as a promising drug target for cardiovascular health and muscle regeneration. While prior research unveiled the structural versatility of APJR in coupling to Gi proteins as a monomer or dimer, the dynamic regulation within the APJR dimer during activation remains poorly understood. In this study, we present the structures of the APJR dimer and monomer complexed with its endogenous ligand apelin-13. In the dimeric structure, apelin-13 binds exclusively to one protomer that is coupled with Gi proteins, revealing a distinct ligand-binding behavior within APJR homodimers. Furthermore, binding of an antagonistic antibody induces a more compact dimerization by engaging both protomers. Notably, structural analyses of the APJR dimer complexed with an agonistic antibody, with or without Gi proteins, suggest that G protein coupling may promote the dissociation of the APJR dimer during activation. These findings underscore the intricate interplay between ligands, dimerization, and G protein coupling in regulating APJR signaling pathways.
- 2 January 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-12
Open AccessStructural insights into the regulation of monomeric and dimeric apelin receptor
The apelin receptor (APJR) emerges as a promising drug target for cardiovascular health and muscle regeneration. While prior research unveiled the structural versatility of APJR in coupling to Gi proteins as a monomer or dimer, the dynamic regulation within the APJR dimer during activation remains poorly understood. In this study, we present the structures of the APJR dimer and monomer complexed with its endogenous ligand apelin-13. In the dimeric structure, apelin-13 binds exclusively to one protomer that is coupled with Gi proteins, revealing a distinct ligand-binding behavior within APJR homodimers. Furthermore, binding of an antagonistic antibody induces a more compact dimerization by engaging both protomers. Notably, structural analyses of the APJR dimer complexed with an agonistic antibody, with or without Gi proteins, suggest that G protein coupling may promote the dissociation of the APJR dimer during activation. These findings underscore the intricate interplay between ligands, dimerization, and G protein coupling in regulating APJR signaling pathways.
- Open Access
- 2 September 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-12
Structural basis of Frizzled 4 in recognition of Dishevelled 2 unveils mechanism of WNT signaling activation
WNT signaling is fundamental in development and homeostasis, but how the Frizzled receptors (FZDs) propagate signaling remains enigmatic. Here, we present the cryo-EM structure of FZD4 engaged with the DEP domain of Dishevelled 2 (DVL2), a key WNT transducer. We uncover a distinct binding mode where the DEP finger-loop inserts into the FZD4 cavity to form a hydrophobic interface. FZD4 intracellular loop 2 (ICL2) additionally anchors the complex through polar contacts. Mutagenesis validates the structural observations. The DEP interface is highly conserved in FZDs, indicating a universal mechanism by which FZDs engage with DVLs. We further reveal that DEP mimics G-protein/β-arrestin/GRK to recognize an active conformation of receptor, expanding current GPCR engagement models. Finally, we identify a distinct FZD4 dimerization interface. Our findings delineate the molecular determinants governing FZD/DVL assembly and propagation of WNT signaling, providing long-sought answers underlying WNT signal transduction.
- 2 September 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-12
Open AccessStructural basis of Frizzled 4 in recognition of Dishevelled 2 unveils mechanism of WNT signaling activation
WNT signaling is fundamental in development and homeostasis, but how the Frizzled receptors (FZDs) propagate signaling remains enigmatic. Here, we present the cryo-EM structure of FZD4 engaged with the DEP domain of Dishevelled 2 (DVL2), a key WNT transducer. We uncover a distinct binding mode where the DEP finger-loop inserts into the FZD4 cavity to form a hydrophobic interface. FZD4 intracellular loop 2 (ICL2) additionally anchors the complex through polar contacts. Mutagenesis validates the structural observations. The DEP interface is highly conserved in FZDs, indicating a universal mechanism by which FZDs engage with DVLs. We further reveal that DEP mimics G-protein/β-arrestin/GRK to recognize an active conformation of receptor, expanding current GPCR engagement models. Finally, we identify a distinct FZD4 dimerization interface. Our findings delineate the molecular determinants governing FZD/DVL assembly and propagation of WNT signaling, providing long-sought answers underlying WNT signal transduction.
- 13 July 2024
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 146 (29) , 20045-20058
Structural Mass Spectrometry Captures Residue-Resolved Comprehensive Conformational Rearrangements of a G Protein-Coupled Receptor
G protein-coupled receptor (GPCR) structural studies with in-solution spectroscopic approaches have offered distinctive insights into GPCR activation and signaling that highly complement those yielded from structural snapshots by crystallography or cryo-EM. While most current spectroscopic approaches allow for probing structural changes at selected residues or loop regions, they are not suitable for capturing a holistic view of GPCR conformational rearrangements across multiple domains. Herein, we develop an approach based on limited proteolysis mass spectrometry (LiP-MS) to simultaneously monitor conformational alterations of a large number of residues spanning both flexible loops and structured transmembrane domains for a given GPCR. To benchmark LiP-MS for GPCR conformational profiling, we studied the adenosine 2A receptor (A(2A)R) in response to different ligand binding (agonist/antagonist/allosteric modulators) and G protein coupling. Systematic and residue-resolved profiling of A(2A)R conformational rearrangements by LiP-MS precisely captures structural mechanisms in multiple domains underlying ligand engagement, receptor activation, and allostery, and may also reflect local conformational flexibility. Furthermore, these residue-resolution structural fingerprints of the A(2A)R protein allow us to readily classify ligands of different pharmacology and distinguish the G protein-coupled state. Thus, our study provides a new structural MS approach that would be generalizable to characterizing conformational transition and plasticity for challenging integral membrane proteins.
- 13 July 2024
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 146 (29) , 20045-20058
Structural Mass Spectrometry Captures Residue-Resolved Comprehensive Conformational Rearrangements of a G Protein-Coupled Receptor
G protein-coupled receptor (GPCR) structural studies with in-solution spectroscopic approaches have offered distinctive insights into GPCR activation and signaling that highly complement those yielded from structural snapshots by crystallography or cryo-EM. While most current spectroscopic approaches allow for probing structural changes at selected residues or loop regions, they are not suitable for capturing a holistic view of GPCR conformational rearrangements across multiple domains. Herein, we develop an approach based on limited proteolysis mass spectrometry (LiP-MS) to simultaneously monitor conformational alterations of a large number of residues spanning both flexible loops and structured transmembrane domains for a given GPCR. To benchmark LiP-MS for GPCR conformational profiling, we studied the adenosine 2A receptor (A(2A)R) in response to different ligand binding (agonist/antagonist/allosteric modulators) and G protein coupling. Systematic and residue-resolved profiling of A(2A)R conformational rearrangements by LiP-MS precisely captures structural mechanisms in multiple domains underlying ligand engagement, receptor activation, and allostery, and may also reflect local conformational flexibility. Furthermore, these residue-resolution structural fingerprints of the A(2A)R protein allow us to readily classify ligands of different pharmacology and distinguish the G protein-coupled state. Thus, our study provides a new structural MS approach that would be generalizable to characterizing conformational transition and plasticity for challenging integral membrane proteins.
- Open Access
- 13 July 2024
- Published by Elsevier in Cell Reports
- Vol. 43 (7) , 114505
The versatile binding landscape of the TAAR1 pocket for LSD and other antipsychotic drug molecules
- 13 July 2024
- Published by Elsevier in Cell Reports
- Vol. 43 (7) , 114505
Open AccessThe versatile binding landscape of the TAAR1 pocket for LSD and other antipsychotic drug molecules
- Open Access
- 25 June 2024
- Published by Springer Nature in Cell Discovery
- Vol. 10 (1) , 1-4
Molecular recognition of the atypical chemokine-like peptide GPR15L by its cognate receptor GPR15
- 25 June 2024
- Published by Springer Nature in Cell Discovery
- Vol. 10 (1) , 1-4
Open AccessMolecular recognition of the atypical chemokine-like peptide GPR15L by its cognate receptor GPR15